NEW YORK--(BUSINESS WIRE)--Nov 7, 2018--The Ontario Bioscience Innovation Organization (OBIO ® ) is honoured to announce the conclusion of the successful Canadian Health Investment Showcase which took place in New York, NY, on November 5 and 6, 2018.

At the Showcase, 21 representatives from Canada’s highest potential health science companies and more than 35 premier US investors engaged in hundreds of meetings and created exciting investment and collaboration opportunities.

“OBIO is proud of the success of the Canadian Health Investment Showcase which has demonstrated the incredibly high quality of Canadian health science companies to US investors,” said Gail Garland, President and CEO of OBIO. “The success of this showcase reveals the high-quality deal flow in Canada for US investors and establishes new networks for Canadian companies in the US.”

Over two days at the Consulate General of Canada in New York, OBIO’s Canadian Health Investment Showcase profiled elite US investment firms Aisling Capital and Canaan Partners as well as expertise from Norton Rose Fulbright and Biotagenics in a robust discussion on the feasibility of cross-border investing. Silicon Valley Bank provided a keynote address on trends in health investing this year and Cresco Advisors and Edison Partners shared investor insights in the digital health space.

“OBIO’s Canadian Health Investment Showcase was a highly effective event that highlighted both the world-class calibre of Canadian health science technologies and companies, as well as the opportunity for US investors in Canada,” said Dennis Purcell, Founder and Senior Advisor at Aisling Capital. “I look forward to developing the opportunities that have come out of this event and to working with OBIO in the future.”

As Canadian health science companies scale and grow here, attracting global capital and building networks of investors is of paramount importance.

“OBIO’s Canadian Health Investment Showcase was an unprecedented success for both Canadian health science companies and the industry as a whole,” said Dr. Jeremy Bridge-Cook, CEO of Rna Diagnostics. “I am proud to have been part of the delegation of companies at the Canadian Health Investment Showcase and I congratulate OBIO on delivering an unparalleled investor event for Canadian companies.”

The Ontario Bioscience Innovation Organization (OBIO ® ) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health technologies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.

For more information please visit www.obio.ca and follow OBIO on Twitter @OBIOscience.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005960/en/

CONTACT: OBIO

Grant Burns, 416-848-6839 ext. 106

Director, Public Affairs and Communications

grantburns@obio.ca

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY RESEARCH SCIENCE GENERAL HEALTH

SOURCE: Ontario Bioscience Innovation Organization

Copyright Business Wire 2018.

PUB: 11/07/2018 05:04 PM/DISC: 11/07/2018 05:04 PM

http://www.businesswire.com/news/home/20181107005960/en

Copyright Business Wire 2018.